What Every Family Medicine Physician Should Know About Hepatic Encephalopathy: Recognition, Differential Diagnosis, Diagnostic Testing, and Appropriate Referral
EHA2026: New Data on the Management of Anemia in Myelofibrosis
LIVE from ASCO26: New Data on CelMOD Therapy for Multiple Myeloma
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Symptoms, Diagnosis, and Contemporary Treatment Strategies
ATTR-CM : Updated epidemiology, diagnosis, sex disparities and latest TTR stabilizer data from 2026 so far!
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients with Psoriatic Arthritis
Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Therapeutics
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitors for Difficult-to-Control Hypertension at ESC2025
Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia
A Primary Care Perspective on the Diagnosis and Treatment of Irritable Bowel Syndrome
Optimizing Care for HCM Patients: Evidence-Based, Pathology-Targeted Management for All
Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)